The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-1-(3-chloro-4-methylphenyl)-4-((6-nitrobenzo[d][1,3]dioxol-5-yl)methylene)pyrazolidine-3,5-dione ID: ALA5289470
Max Phase: Preclinical
Molecular Formula: C18H12ClN3O6
Molecular Weight: 401.76
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(N2NC(=O)/C(=C/c3cc4c(cc3[N+](=O)[O-])OCO4)C2=O)cc1Cl
Standard InChI: InChI=1S/C18H12ClN3O6/c1-9-2-3-11(6-13(9)19)21-18(24)12(17(23)20-21)4-10-5-15-16(28-8-27-15)7-14(10)22(25)26/h2-7H,8H2,1H3,(H,20,23)/b12-4-
Standard InChI Key: RKCOYYSPCQGKNT-QCDXTXTGSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
12.4227 -28.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0901 -28.7540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7588 -28.2707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5035 -27.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6794 -27.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9875 -26.8153 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5394 -28.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7086 -29.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4920 -29.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1068 -29.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9330 -28.2274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1499 -27.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6378 -28.5228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1943 -26.8191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5295 -26.0652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3479 -25.9825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3736 -24.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0420 -25.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8914 -29.2933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6619 -30.3969 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.2173 -25.4947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8859 -26.2503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7287 -24.8299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1979 -24.5614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6839 -25.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4688 -24.9725 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4678 -24.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6823 -23.8928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
4 6 2 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
1 13 2 0
5 14 2 0
14 15 1 0
15 16 2 0
16 25 1 0
24 17 1 0
17 18 2 0
18 15 1 0
10 19 1 0
9 20 1 0
21 22 2 0
21 23 1 0
18 21 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
M CHG 2 21 1 23 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 401.76Molecular Weight (Monoisotopic): 401.0415AlogP: 2.75#Rotatable Bonds: 3Polar Surface Area: 111.01Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.49CX Basic pKa: ┄CX LogP: 3.11CX LogD: 2.44Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.37Np Likeness Score: -1.54
References 1. Goeckeler-Fried JL, Aldrin Denny R, Joshi D, Hill C, Larsen MB, Chiang AN, Frizzell RA, Wipf P, Sorscher EJ, Brodsky JL.. (2021) Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination., 48 [PMID:34246753 ] [10.1016/j.bmcl.2021.128243 ]